tradingkey.logo
Search
Markets
Watchlist
News
Analysis
Tools
Stock Screener
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
tradingkey.logo
Search

NeuroOne Medical Technologies Corp

NMTC
Add to Watchlist
1.690USD
-0.010-0.59%
Close 07-31 16:00（ET）Quotes delayed by 15 min
14.09MMarket Cap
LossP/E TTM

NeuroOne Medical Technologies Corp

1.690
-0.010-0.59%
Overview
Financials
Discussions
Analysis
Company
Financial SummaryIncome StatementBalance SheetCash Flow Statement

Overview

Financials

Discussions

Analysis

Company

Financial SummaryIncome StatementBalance SheetCash Flow Statement

NMTC Financials

See NeuroOne Medical Technologies Corp's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

NeuroOne Medical Technologies Corp Earnings Date

Latest Release
May 12, 2026
EPS / Forecast
-1.47/-0.23
Revenue / Forecast
2.39M/2.58M
See Upcoming Earnings >>
Period
FY2025 Earnings
Revenue(YoY)
12.10M
250.35%
EPS(YoY)
-0.54
80.49%
Analyst Rating
BUY
2026/07/31
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q2
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
Financial Indicators
EPS
43.86%-0.25
-149.35%-0.17
71.22%-0.03
69.48%-0.03
70.63%-0.07
141.53%0.06
20.18%-0.11
48.73%-0.10
-15.80%-0.25
-30.57%-0.14
---0.14
---0.20
---0.21
---0.11
---0.63
----
----
----
----
----
Revenue
72.46%2.39M
-53.90%2.89M
906.64%2.74M
105.39%1.70M
0.67%1.39M
541.76%6.27M
-65.20%272.28K
31.10%825.78K
195.45%1.38M
-37.72%977.65K
-61.09%782.52K
1865.45%629.91K
1174.26%466.18K
3812.48%1.57M
3672.81%2.01M
-44.31%32.05K
-4.61%36.58K
-57.20%40.12K
-97.23%53.31K
--57.55K
Net Profit
8.14%-2.09M
-180.54%-1.44M
51.67%-1.62M
45.77%-1.50M
20.47%-2.27M
153.37%1.79M
-6.87%-3.35M
20.22%-2.77M
18.95%-2.86M
-93.04%-3.34M
-128.12%-3.14M
-25.69%-3.47M
-15.20%-3.52M
38.28%-1.73M
48.00%-1.37M
6.50%-2.76M
-27.74%-3.06M
-43.28%-2.81M
-366.67%-2.64M
58.38%-2.95M
Net Margin
46.74%-87.22%
-274.69%-49.71%
95.20%-59.08%
73.60%-88.49%
21.00%-163.76%
108.32%28.46%
-207.14%-1230.55%
39.14%-335.14%
72.57%-207.30%
-209.95%-342.14%
---400.65%
---550.68%
---755.69%
---110.38%
---471.67%
----
----
----
----
----
Gross Margin
-3.24%53.81%
-30.98%54.20%
7.65%55.77%
58.02%53.94%
99.41%55.61%
188.27%78.53%
72.96%51.81%
-11.76%34.13%
312.67%27.89%
-70.36%27.24%
--29.95%
--38.68%
--6.76%
--91.92%
--88.59%
----
----
----
----
----
Debt to assets ratio
-70.45%9.02%
-65.11%9.41%
-70.53%11.75%
--9.62%
--30.53%
--26.96%
--39.86%
----
----
--0.00%
--0.00%
--0.00%
--0.00%
--0.00%
--0.00%
----
----
----
----
----
Income Statement
Revenue
72.46%2.39M
-53.90%2.89M
906.64%2.74M
105.39%1.70M
0.67%1.39M
541.76%6.27M
-65.20%272.28K
31.10%825.78K
195.45%1.38M
-37.72%977.65K
-61.09%782.52K
1865.45%629.91K
1174.26%466.18K
3812.48%1.57M
3672.81%2.01M
-44.31%32.05K
-4.61%36.58K
-57.20%40.12K
-97.23%53.31K
--57.55K
Operating profit
21.61%-2.10M
-199.77%-1.71M
51.32%-1.37M
32.47%-1.89M
7.14%-2.68M
150.47%1.71M
11.00%-2.82M
20.41%-2.79M
17.44%-2.89M
-90.01%-3.39M
-126.02%-3.16M
-27.12%-3.51M
-14.25%-3.50M
36.48%-1.78M
47.04%-1.40M
9.01%-2.76M
-27.72%-3.06M
-31.07%-2.81M
-2151.75%-2.64M
-90.46%-3.03M
Net Profit
8.14%-2.09M
-180.54%-1.44M
51.67%-1.62M
45.77%-1.50M
20.47%-2.27M
153.37%1.79M
-6.87%-3.35M
20.22%-2.77M
18.95%-2.86M
-93.04%-3.34M
-128.12%-3.14M
-25.69%-3.47M
-15.20%-3.52M
38.28%-1.73M
48.00%-1.37M
6.50%-2.76M
-27.74%-3.06M
-43.28%-2.81M
-366.67%-2.64M
58.38%-2.95M
Balance Sheet
Current assets
97.22%7.40M
41.24%8.07M
120.83%10.23M
148.95%10.17M
-20.29%3.75M
12.15%5.71M
-36.67%4.63M
-16.26%4.09M
-25.91%4.71M
-43.20%5.09M
-39.94%7.31M
-55.36%4.88M
-52.71%6.36M
-45.90%8.97M
66.97%12.18M
17.88%10.93M
18.38%13.44M
125.82%16.58M
75.50%7.29M
137.48%9.27M
Total current liabilities
-4.19%1.69M
-19.89%1.26M
4.06%2.30M
-15.68%1.43M
14.47%1.76M
13.57%1.57M
23.46%2.21M
-3.26%1.69M
-0.64%1.54M
3.63%1.38M
-42.15%1.79M
114.59%1.75M
91.35%1.55M
25.64%1.33M
162.22%3.10M
9.06%814.52K
7.98%810.23K
-82.82%1.06M
-49.84%1.18M
-90.71%746.85K
Total assets
76.48%7.86M
32.08%8.58M
100.85%10.79M
120.24%10.82M
-17.39%4.46M
11.54%6.49M
-33.68%5.37M
-14.68%4.91M
-25.12%5.39M
-39.73%5.82M
-36.85%8.10M
-50.24%5.76M
-48.86%7.21M
-43.78%9.66M
61.52%12.82M
17.96%11.57M
18.22%14.09M
117.15%17.18M
66.78%7.94M
119.81%9.81M
Total liabilities
-25.20%2.49M
-38.87%2.18M
-18.36%3.71M
38.99%2.64M
116.22%3.33M
153.46%3.56M
146.11%4.55M
3.49%1.90M
-7.88%1.54M
-5.66%1.40M
-42.58%1.85M
92.85%1.84M
73.06%1.67M
20.46%1.49M
132.43%3.22M
-0.14%952.48K
-8.59%966.27K
-81.00%1.24M
-48.60%1.38M
-88.63%953.82K
Total equity
377.29%5.37M
118.10%6.40M
760.39%7.07M
171.52%8.18M
-70.79%1.13M
-33.56%2.94M
-86.85%822.01K
-23.20%3.01M
-30.33%3.85M
-45.93%4.42M
-34.93%6.25M
-63.07%3.92M
-57.84%5.53M
-48.76%8.17M
46.54%9.60M
19.91%10.62M
20.83%13.12M
1032.53%15.95M
217.20%6.55M
325.50%8.85M
Cash Flow Statement
Net operating income
-2001.23%-1.33M
-3662.99%-3.12M
42.79%-1.53M
38.00%-1.46M
97.09%-63.23K
97.83%-82.80K
8.13%-2.67M
19.72%-2.36M
38.75%-2.18M
-9.08%-3.81M
-385.20%-2.90M
-11.52%-2.94M
-10.24%-3.55M
-30.35%-3.49M
150.16%1.02M
-15.17%-2.64M
-35.37%-3.22M
-40.69%-2.68M
-844.24%-2.03M
-87.21%-2.29M
Net investment
-1114.63%-38.52K
-66.92%-40.75K
71.26%-10.61K
-194.22%-43.55K
89.89%-3.17K
34.24%-24.42K
26.37%-36.91K
-101.72%-14.80K
-101.72%-31.36K
-346.41%-37.13K
98.35%-50.12K
1687.03%860.71K
2054.91%1.82M
124.51%15.07K
-8546.56%-3.04M
-81.32%-54.23K
-4432.25%-93.32K
---61.49K
37.70%-35.11K
-15.74%-29.91K
Net financing
141.62%609.62K
167.66%147.82K
-97.37%66.98K
427.16%8.23M
-87.13%252.31K
-118.13%-218.47K
-51.00%2.54M
-0.02%1.56M
196.12%1.96M
7768.90%1.21M
--5.19M
--1.56M
205677.95%661.96K
-100.13%-15.71K
100.00%0.00
-100.00%0.00
-100.00%-322.00
140.62%12.02M
-545.64%-24.98K
-99.17%35.88K

FAQs

What is the total revenue of NeuroOne Medical Technologies Corp?

According to NeuroOne Medical Technologies Corp's FY2025 earnings report, its total revenue reached 12.10M, with a year-on-year change of 3.45M.

What are the current assets of NeuroOne Medical Technologies Corp?

According to NeuroOne Medical Technologies Corp's FY2025 earnings report, its current assets were 10.23M, with a year-on-year change of 120.83.

What are the total assets of NeuroOne Medical Technologies Corp?

According to NeuroOne Medical Technologies Corp's FY2025 earnings report, its total assets of NeuroOne Medical Technologies Corp were 10.79M, with a year-on-year change of 100.85.

What are the total liabilities of NeuroOne Medical Technologies Corp?

According to NeuroOne Medical Technologies Corp's FY2025 earnings report, its total liabilities of NeuroOne Medical Technologies Corp were 3.71M, with a year-on-year change of -18.36.

What is the total equity of NeuroOne Medical Technologies Corp?

According to NeuroOne Medical Technologies Corp's FY2025 earnings report, its total equity of NeuroOne Medical Technologies Corp was 7.07M, with a year-on-year change of 760.39.

What is the net operating income of NeuroOne Medical Technologies Corp?

According to NeuroOne Medical Technologies Corp's FY2025 earnings report, its net operating income of NeuroOne Medical Technologies Corp was -4.23M, with a year-on-year change of 64.45.

What is the net investment of NeuroOne Medical Technologies Corp?

According to NeuroOne Medical Technologies Corp's FY2025 earnings report, its net investment of NeuroOne Medical Technologies Corp was -81.74K, with a year-on-year change of 31.99.

What is the net financing of NeuroOne Medical Technologies Corp?

According to NeuroOne Medical Technologies Corp's FY2025 earnings report, its net financing of NeuroOne Medical Technologies Corp was 8.33M, with a year-on-year change of 14.55.

What is the Earnings Per Share (EPS) of NeuroOne Medical Technologies Corp?

According to NeuroOne Medical Technologies Corp's FY2025 earnings report, its Earnings Per Share (EPS) was -0.54, with a year-on-year change of 80.49.

What is the net income of NeuroOne Medical Technologies Corp?

According to NeuroOne Medical Technologies Corp's FY2025 earnings report, its net income was -3.61M, with a year-on-year change of 70.73.

What is the net margin of NeuroOne Medical Technologies Corp?

According to NeuroOne Medical Technologies Corp's FY2025 earnings report, its net profit margin was -29.80, with a year-on-year change of 91.65.

What is the gross margin of NeuroOne Medical Technologies Corp?

According to NeuroOne Medical Technologies Corp's FY2025 earnings report, its gross margin was 67.30, with a year-on-year change of 115.23.

What is the debt-to-asset ratio of NeuroOne Medical Technologies Corp?

According to NeuroOne Medical Technologies Corp's FY2025 earnings report, its debt-to-asset ratio was 11.75, with a year-on-year change of -70.53.

What is the Return on Equity (ROE) of NeuroOne Medical Technologies Corp?

According to NeuroOne Medical Technologies Corp's FY2025 earnings report, its Return on Equity (ROE) was -91.34, with a year-on-year change of 73.78.

What is the Return on Assets (ROA) of NeuroOne Medical Technologies Corp?

According to NeuroOne Medical Technologies Corp's FY2025 earnings report, its Return on Assets (ROA) was -44.63, with a year-on-year change of 75.60.

What is the operating profit of NeuroOne Medical Technologies Corp?

According to NeuroOne Medical Technologies Corp's FY2025 earnings report, its operating profit was -4.23M, with a year-on-year change of 64.45.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.
General Terms of Use
Privacy Policy
Cookie Policy